CAS 1609

Known as: CAS-1609 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-1999
012319951999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
An overview of the different heterocyclic NO-releasing compounds is given. Mesoionic heterocycles like sydnone imines are one… (More)
Is this relevant?
1997
1997
Synthetic exogenous lysophosphatidylcholine (LPC) was used to induce leukocyte-endothelial cell interaction, utilizing intravital… (More)
Is this relevant?
1995
1995
We studied the effects of a novel organic nitric oxide (NO) donor, 4-hydroxymethyl-furazan-3-carboxylic acid-2-oxide (CAS-1609… (More)
Is this relevant?
1995
1995
In the present study a novel nitric oxide (NO) donor, CAS-1609, was utilized as a means of coronary NO replenishment in a canine… (More)
Is this relevant?
1995
1995
1. This study examines the cardiovascular effects of CAS 1609 (4-hydroxymethyl-furoxan-3-carboxamide) in vitro as well as in vivo… (More)
Is this relevant?